Department of Pediatric Endocrinology, Regina Margherita Children's Hospital, City of Health and Science University Hospital of Turin, Turin, Italy.
Department of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.
Endocrine. 2021 Jan;71(1):122-129. doi: 10.1007/s12020-020-02370-w. Epub 2020 Jun 7.
The incidence of primary congenital hypothyroidism (CH) has grown progressively and literature data indicate an association between CH and congenital malformations. The purpose of this study is to establish the current incidence of CH in the Italian Region of Piedmont and verify the relationship between CH diagnostic categories and associated malformations.
The biochemical and clinical data of 105 newborns with CH diagnosed in the period January 2014 to December 2019 were analyzed.
The incidence of CH in the Italian Piedmont region in the 2014-2019 period increased to 1:1090. Thyroid dysgenesis was responsible for 47.6% (50/105) of all cases, with agenesis in 14.3% (15/105), while ectopia and hypoplasia in 23.8% (25/105) and 9.5% (10/105) of the cases, respectively; dyshormonogenesis defects were found in 52.4% (55/105) of cases. Congenital extra-thyroid anomalies were identified in 33/105 (31.4%) of newborns with CH and mainly involve the cardiac system (17/85, 16.1%), urogenital tract (7/85, 6.7%), gastrointestinal tract (5/105, 4.8%), and the musculoskeletal system (5/105, 4.8%). The highest rate of malformations was observed in patients with thyroid agenesis and dyshormonogenesis, respectively, in 53.5% and 36.4% of cases, while in the presence of thyroid ectopia and hypoplasia, the rate was 12% and 20%, respectively, (p = 0.03).
In the Italian region of Piedmont, the incidence of primary CH has been increased over time, with a variation in the percentage of the different forms of CH. Congenital malformations, especially affecting the cardiovascular, urogenital, gastrointestinal, and musculoskeletal systems, seem to be mainly associated with thyroid agenesis or defects in hormonogenesis.
原发性先天性甲状腺功能减退症(CH)的发病率呈逐渐上升趋势,文献资料表明 CH 与先天性畸形之间存在关联。本研究旨在确定意大利皮埃蒙特地区目前的 CH 发病率,并验证 CH 诊断类别与相关畸形之间的关系。
分析了 2014 年 1 月至 2019 年 12 月期间在意大利皮埃蒙特地区诊断为 CH 的 105 例新生儿的生化和临床数据。
在 2014-2019 年期间,意大利皮埃蒙特地区 CH 的发病率增加至 1:1090。甲状腺发育不全导致所有病例的 47.6%(50/105),其中 14.3%(15/105)为无甲状腺,而异位和发育不良分别占 23.8%(25/105)和 9.5%(10/105);52.4%(55/105)的病例发现有激素生成缺陷。在 33/105(31.4%)患有 CH 的新生儿中发现了先天性甲状腺外异常,主要涉及心脏系统(17/85,16.1%)、泌尿生殖系统(7/85,6.7%)、胃肠道(5/105,4.8%)和肌肉骨骼系统(5/105,4.8%)。在甲状腺发育不全和激素生成缺陷的患者中,畸形发生率最高,分别为 53.5%和 36.4%,而在甲状腺异位和发育不良的患者中,发生率分别为 12%和 20%,(p=0.03)。
在意大利皮埃蒙特地区,原发性 CH 的发病率随着时间的推移有所增加,不同形式的 CH 的比例也有所变化。先天性畸形,特别是影响心血管、泌尿生殖、胃肠道和肌肉骨骼系统的畸形,似乎主要与甲状腺发育不全或激素生成缺陷有关。